The Middle EAST Aminophylline Market was valued at USD 0.12 billion in 2024 and is projected to reach USD 0.25 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of respiratory diseases, the rising demand for bronchodilator medications, and the expanding healthcare infrastructure across the region. The...